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Abstract
Sinusoidal transport of reduced glutathione (GSH) is a carrier-mediated process. Perfused liver and isolated hepatocyte
models revealed a low-affinity transporter with sigmoidal kinetics (KmV3.2^12 mM), while studies with sinusoidal
membrane vesicles (SMV) revealed a high-affinity unit (KmV0.34 mM) besides a low-affinity one (KmV3.5^7 mM).
However, in SMV, both the high- and low-affinity units manifested Michaelis^Menten kinetics of GSH transport. We have
now established the sigmoidicity of the low-affinity unit (KmV9) in SMV, consistent with other models, while the high-
affinity unit has been retained intact with Michaelis^Menten kinetics (KmV0.13 mM). We capitalized on the negligible cross-
contributions of the two units to total transport at the low and high ends of GSH concentrations and investigated their
characteristics separately, using radiation inactivation, as we did in canalicular GSH transport (Am. J. Physiol. 274 (1998)
G923^G930). We studied the functional sizes of the proteins that mediate high- and low-affinity GSH transport in SMV by
inactivation of transport at low (trace and 0.02 mM) and high (25 and 50 mM) concentrations of GSH. The low-affinity unit
in SMV was much less affected by radiation than in canalicular membrane vesicles (CMV). The target size of the low-affinity
sinusoidal GSH transporter appeared to be considerably smaller than both the canalicular low- and high-affinity
transporters. The high-affinity unit in SMV was markedly inactivated upon irradiation, revealing a single protein structure
with a functional size of V70 kDa. This size is indistinguishable from that of the high-affinity GSH transporter in CMV
reported earlier. ß 2000 Elsevier Science B.V. All rights reserved.
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1. Introduction
Reduced glutathione (GSH), an endogenous anti-
oxidant, is exported from hepatocytes across baso-
lateral (sinusoidal) and apical plasma membrane do-
mains, with both components of e¥ux manifesting
maturational changes [1]. Sinusoidal e¥ux serves as
the principal source of plasma GSH, cysteine and
cystine [2^5]. The latter two arise from extracellular
hydrolysis of plasma GSH (by the ecto-enzyme Q-
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glutamyl-transpeptidase) to cysteine, which is subse-
quently oxidized to cystine. Using tracer-kinetic
methods in vivo and multicompartmental analysis
and modeling, we have de¢ned the kinetics of plasma
GSH, cysteine and cystine turnover and shown that,
in mature, ad libitum-fed rats, essentially all of plas-
ma cysteine and cystine are derived from plasma
GSH [4,5]. Thus, sinusoidal GSH e¥ux plays a crit-
ical role in the inter-organ homeostasis of GSH and
thiol-disul¢des and regulation of the redox status of
plasma. Since certain disul¢des (cystine) and thiol-
reducing agents (DTT) have been shown to modulate
hepatic sinusoidal GSH transport [6,7], it is possible
that sinusoidal GSH e¥ux may be modulated by the
redox status of hepatic cytosol and/or blood plasma.
Such modulatory e¡ects, mediated by the redox sta-
tus of intra- and extrahepatic environment, could
serve as critical determinants of changes in GSH ho-
meostasis during sustained oxidative injury as well as
aging [8,9].
Using a variety of experimental models ranging
from isolated perfused livers [10] to freshly isolated
and/or cultured hepatocytes [6,7,11,12], to SMV
[13,14], sinusoidal GSH transport has been found
to be saturable and inhibitable by various amino
acids and organic anions in unconjugated and con-
jugated forms. These include trans-inhibition by me-
thionine and cystathionine [15^17] and cis-inhibition
by bilirubin (in unconjugated and mono- and di-glu-
curonide forms) and BSP-SG [10,17^19]. These ¢nd-
ings have indicated the involvement of carrier pro-
teins in sinusoidal transport of GSH which remain to
be directly identi¢ed since a putative sinusoidal
transporter clone [20] proved to represent an Esche-
richia coli cloning artifact (Kaplowitz et al., unpub-
lished observations).
It is known that organic anion transporter poly-
peptide 1 (oatp1) may mediate the transport of glu-
tathione, possibly in exchange with taurocholate [21].
However, the transport of taurocholate by oatp1 was
neither modulated by DTT nor inhibited by methio-
nine and cystathionine [21]. Furthermore, the trans-
port of substrates by oatp1 is expected to be an elec-
troneutral process, whereas e¥ux of GSH with
sinusoidal characteristics in a number of models is
electrogenic [6,7,11^14]. Therefore, the contribution
of oatp1 to GSH transport in hepatocytes is not clear
and is presumed to be minimal. Thus, it is plausible
that other candidate proteins may exist as the prin-
cipal transporter(s) of hepatic sinusoidal GSH.
Heretofore, perfused liver, freshly isolated and cul-
tured hepatocyte models have consistently and un-
equivocally revealed the presence of a low-a⁄nity
transport unit that displays non-Michaelis^Menten,
i.e., sigmoidal kinetics (KmV3.2^12 mM; Hill coef-
¢cient nV2^3). On the other hand, studies with
SMV succeeded in identifying an additional, high-
a⁄nity unit with Michaelis^Menten kinetics
(KmV0.34 mM) [14]. This high-a⁄nity unit was
not revealed in studies of sinusoidal GSH e¥ux in
the perfused liver and isolated cell models, in all like-
lihood due to the di⁄culty of measurement and scat-
ter of the intra- and extracellular GSH data at di-
minishing cellular GSH concentrations. However,
while both the high- and low-a⁄nity units were re-
vealed in earlier SMV studies [13,14], the low a⁄nity
unit (KmV3.5^7 mM) failed to manifest sigmoidal
kinetics of transport.
In pilot studies, attempting to re¢ne and improve
our membrane fractionation and transport measure-
ment techniques, we were able for the ¢rst time to
reveal the sigmoidicity in the kinetics of GSH trans-
port by the low-a⁄nity unit in SMV, while the high-
a⁄nity, Michaelis^Menten unit was retained. This
outcome prompted us to design the present study
with the following purposes in mind: (1) de¢ne the
kinetics of GSH transport in SMV and determine the
kinetic parameters of the high- and low-a⁄nity units
to assess the cross-contributions to total transport by
the two units; (2) If cross-contributions are negligible
at the low and high ends of GSH concentrations, use
radiation inactivation of GSH transport in SMV to
study the characteristics of each transporter individ-
ually, as we did earlier in GSH transport in CMV
[22].
Radiation inactivation is a unique and powerful
tool that allows the estimation of the functional
size of proteins in situ [23,24]. It can be applied to
detect the presence of multiple proteins with distinct
sizes, which may share common functions. As stated
above, although oatp1 has been identi¢ed as a can-
didate GSH transporter, it cannot account for all of
the observed functional and kinetic features of hep-
atic sinusoidal GSH transport. In all likelihood, oth-
er protein(s) that mediate GSH transport remain to
be identi¢ed. Radiation inactivation can reveal the
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presence of multiple GSH transporters, if their func-
tional sizes are distinct, and thus enable us to com-
pare their sizes with oatp1. Furthermore, functional
interaction of the transporter(s) with other distinct
proteins can also be tested using target size analysis.
We have earlier applied the radiation inactivation
technique to successfully identify and study the prop-
erties of the high- and low-a⁄nity GSH transporters
in canalicular membrane vesicles (CMV) [22]. In our
SMV model, the presence of a high-a⁄nity Michae-
lis^Menten unit suggests the involvement of a protein
distinct from the low-a⁄nity carrier. The sigmoidal
kinetics of the low-a⁄nity transport could indicate
positive cooperativity between subunits in an oligo-
meric carrier or between multiple sites on a single
polypeptide. Thus, knowledge of the in situ function-
al size of hepatic sinusoidal GSH transport could
potentially help to clarify the structural basis of the
two a⁄nities for GSH and the sigmoidicity in the
low-a⁄nity transport.
Our studies were designed to answer the following
questions. (1) Does the low a⁄nity unit of GSH
transport exhibit sigmoidal kinetics with character-
istics that result in negligible cross-contribution to
total transport by the high- and low-a⁄nity units
at the low and high ends of GSH concentrations?
(2) If so, are the functional sizes of the high- and
low-a⁄nity units of GSH transport, as determined
by radiation inactivation, distinct from each other?
(3) Is the sigmoidicity of the kinetics of GSH trans-
port by the low-a⁄nity unit due to an oligomeric
association of subunits? (4) What are the compari-
sons among the functional sizes of the sinusoidal
high- and low-a⁄nity transporters of GSH with
those of the canalicular GSH transporters and
oatp1?
2. Materials and methods
2.1. Chemicals and assays
All chemicals were purchased from Sigma Chem-
ical Co. (St. Louis, MO) or other commercial sour-
ces. [35S]GSH (s 100 Ci/mmol), [3H]GSH (s 100 Ci/
mmol), [3H]alanine (s 75 Ci/mmol), [3H]taurocholic
acid (s 2 Ci/mmol), L-[3H]glutamate (s 40 Ci/
mmol), and Aquasol scintillation cocktail were pro-
cured from New England Nuclear (Boston, MA).
The purity and chemical form of every lot of
[35S]GSH was con¢rmed by radio-HPLC [22,25].
5P-Nucleotidase was assayed by HPLC [26]. All other
assays were performed as described before [22]. BSP-
SG was synthesized by the conjugation of BSP and
GSH [27]. The resulting product was further puri¢ed
by size-exclusion chromatography on a Sephacryl S-
200 (Pharmacia Biotech) column (2 l bed volume).
BSP-SG and GSH were sequentially eluted with de-
ionized water. Fractions with BSP-SG were identi¢ed
by alkalizing with 1 N NaOH, followed by measur-
ing absorbance at 580 nm. The fractions containing
BSP-SG were pooled, lyophilized, and stored at
380‡C. BSP-SG was essentially free of GSH and
BSP, as veri¢ed by HPLC [28].
2.2. Animals
Mature (90^135-day-old), male Sprague^Dawley
rats weighing 380^450 g (Harlan Laboratories, San
Diego, CA), were housed in a constant temperature
and humidity environment, with alternating 12-h
light and dark cycles. The rats had access to water
and Purina Rodent Chow ad libitum.
2.3. Isolation and characterization of membrane
vesicles
We prepared SMV essentially by the method of
Meier et al. [29] with certain modi¢cations, which
included an added step of initially passing the liver
tissue through a stainless-steel sieve (No. 18) (VWR
Scienti¢c) to eliminate connective tissue as best pos-
sible, before homogenization. The SMV were sus-
pended in cryoprotective bu¡er with 14% (v/v) glyc-
erol, 1.4% D-sorbitol (w/v), 150 mM KCl, 0.2 mM
CaCl2, 0.2 mM MgCl2, and 10 mM Hepes/Tris (pH
7.5). The purity and enrichment of membrane frac-
tions were determined by marker enzymes as de-
scribed before [22,30]. Storage and handling of the
isolated vesicles were performed exactly as described
before [22].
2.4. Radiation inactivation and target size analyses
SMV were irradiated exactly as described in an
earlier study with CMV [22]. Radiation dosimetry
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and sample handling were performed as described
before [22,31]. The inactivation of 5P-nucleotidase
was again used as an internal control to monitor
and establish the dosimetry and consistency of irra-
diations in individual vesicle preparations [22,32].
Post-irradiation residual transport activity (V) was
normalized to transport activity in the unirradiated
control (Vo) and expressed as %V/Vo. The semi-log
slope of the inactivation curve (ln V/Vo against radi-
ation dose, D) was estimated by ¢tting the data from
both individual experiments and by ¢tting the mean
of residual activities in each group. In cases where a
radiation-insensitive component of activity was
present, the data were analyzed by the inclusion of
a constant in addition to exponentials, as described
before [22,33]. The functional size M (in Da) was
estimated from the rate constant (W) of the exponen-
tial de¢ning the inactivation curve using the relation-
ship, M =317.9U105 W, as described [31].
2.5. Transport studies
The details of our techniques to measure the initial
rates of transport of radiolabeled substrates using the
rapid ¢ltration technique have been described earlier
[22]. We have reduced the time point used to estimate
the initial rates of uptake to 10 s from 15 s, used in
earlier studies [13,30], to ensure staying within the
linear range of uptake at all concentrations of the
substrates. In each preparation and at all substrate
concentrations, the measurements were made in du-
plicate and the mean values of the duplicate determi-
nations were used. The duplicates were reproducible,
indicating the precision of the techniques applied.
The Na-dependent transport of [3H]alanine was de-
termined as described [34]. The uptake of GSH under
voltage-clamped conditions was determined as de-
scribed before [13,22]. Aliquots of unirradiated con-
trol SMV were handled and processed in the same
way as the irradiated ones. The uptake of GSH in
the irradiated SMV was measured in parallel and
compared to the uptake in corresponding unirradi-
ated controls. trans-Stimulation of 2 mM GSH up-
take was determined in SMV that were pre-loaded
with 10 mM GSH by incubating for 30 min at 25‡C.
Control SMV were pre-incubated identically, but
without GSH.
2.6. Separation of the high- and low-a⁄nity
components of GSH transport
We estimated the functional sizes of the two ki-
netic components by inactivating GSH transport at
concentrations where one of the kinetic components
was predominant. At 0.02 WM (trace) and 0.02 mM
GSH, the high-a⁄nity component was the dominant
(s 99.9%) transporter, while at 25 and 50 mM GSH,
v95% of total transport was mediated by the low-
a⁄nity component (see below and Fig. 2).
2.7. Kinetic analysis and ¢tting of transport data
The kinetics of transport and inactivation dose^
response data were analyzed as described previously
[22]. Since cross-contaminating canalicular mem-
brane fraction comprises an estimated 910% of the
total ‘sinusoidal’ membrane fraction [29], we esti-
mated the impact of this degree of cross-contamina-
tion on the kinetics of GSH uptake in our SMV. The
maximal e¡ect of the cross-contribution of contami-
nating CMV to GSH uptake in the SMV fraction
was assessed by correcting SMV transport activity
(nmol (mg protein)31 10 s31) at all concentrations
of GSH for a 10% cross-contribution by CMV as
indicated below:
Corrected GSH transportSMV 
GSH transportSMV30:1U
net GSH transportCMV
where net GSH transportSMV and net GSH trans-
portCMV are the net rates (after subtraction of non-
speci¢c binding at 0^4‡C) of GSH uptake in SMV
and CMV, respectively. The data de¢ning the ki-
netics of GSH transport in CMV, used in these cor-
rections, have been published earlier [22]. SMV used
in the present study were obtained from identical
livers that were also the source of the CMV used
earlier [22]. The SAAM II program (version 1.0.3
for Macintosh) was used to perform non-linear, least
squares regression ¢ts to the kinetic as well as radi-
ation data [35].
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3. Results
3.1. Enrichment, purity and functional integrity of
membrane vesicles
The SMV fractions were enriched 25- to 35-fold in
Na,K-ATPase and de-enriched or not enriched in
intracellular organelle markers (Table 1). The SMV
fractions were V7- and V11-fold enriched in the
canalicular markers Mg2-ATPase and alkaline
phosphatase, respectively (Table 1). We con¢rmed
the morphology and size of SMV by transmission
electron microscopy (not shown). Most of the plasma
membranes were vesiculated, with only a small frac-
tion remaining in the form of sheets. The sizes of
SMV estimated from these micrographs were well
within the range of 0.5^1.0 Wm reported by Meier
et al. [29].
The Na-dependent transport of alanine was used
as a benchmark for the functional integrity and pas-
sive permeability of SMV suspended in cryoprotec-
tive bu¡er [34]. All SMV used in our studies exhib-
ited at least a 2-fold initial overshoot in alanine
uptake over the ¢nal equilibrium plateau (not
shown). The uptake of alanine in the presence of
K was minimal and did not vary signi¢cantly be-
tween preparations, indicating consistently minimal
passive di¡usion or ‘leakiness’ of our SMV. Further-
more, the radiation inactivation of Na-alanine co-
transport was spot-checked to monitor any radia-
tion-induced changes in the passive di¡usion charac-
teristics of SMV. In two independent SMV prepara-
tions, post-irradiation Na-dependent transport of
alanine was found to decay mono-exponentially
(data not shown). The passive di¡usion of alanine
as estimated by its uptake in the presence of K
was unaltered after 6 and 36 Mrad irradiation (not
shown).
3.2. Inactivation of 5P-nucleotidase
In our earlier study of inactivation of GSH trans-
port in CMV, we used the apical membrane marker
5P-nucleotidase as an internal control to monitor the
dosimetry and consistency of irradiations in individ-
ual vesicle preparations [22]. An inherent attribute of
the method we used to fractionate SMV is that
910% of the total ‘sinusoidal’ fraction is comprised
of cross-contaminating canalicular membranes [29].
This property, evident by the presence of the apical
Fig. 1. Inactivation of 5P-nucleotidase. Residual activity in sev-
en independent sinusoidal membrane vesicle preparations were
pooled and the mean values are shown (circles). The solid line
represents the ¢t of a mono-exponential function to the data
weighted by S.E., represented by the bars (see functional size in
text).
Table 1
Analysis of marker enzymes in sinusoidal membrane fractionsa
Marker enzyme Homogenate (speci¢c activity) Relative enrichmentc SMV
Na,K-ATPase 15.2 þ 3.1 29 þ 7.0
Mg2-ATPase 131 þ 5.2 7.4 þ 2.2
Alkaline phosphatase 4.0 þ 0.4 11 þ 6.0
Glucose 6-phosphatase 468 þ 106 0.5 þ 0.3
Acid phosphatase 77 þ 12.1 0.5 þ 0.2
Succinic dehydrogenase 0.33 þ 0.08b 1.4 þ 0.6
aValues are mean þ S.D. of determinations in at least seven membrane preparations (nv7). Speci¢c activities are expressed as nmol
product formed (mg protein)31 min31.
bActivity of succinic dehydrogenase is expressed as MvabsorbanceM (mg protein)31 min31.
cRelative enrichments are expressed as the ratio of speci¢c activity in SMV to the homogenate.
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membrane markers Mg2-ATPase and alkaline phos-
phatase in our SMV (Table 1), was su⁄cient to allow
the detection and quanti¢cation of 5P-nucleotidase in
our SMV by the method we have used before [22,26].
However, as indicated below, the contribution of this
degree of cross-contamination of SMV by canalicular
membrane fractions had a negligible impact on the
kinetics of GSH transport measured in SMV. The
mean residual 5P-nucleotidase activities pooled from
seven independent preparations are shown in Fig. 1,
along with the mono-exponential function obtained
by ¢tting the data. This analysis yielded a target size
of 93 þ 2 kDa (mean þ S.E.). The estimated size is
identical to that reported in our earlier work [22]1
and is in good agreement with the known structure
of 5P-nucleotidase from past observations [32].
3.3. Kinetics of GSH transport in non-irradiated
(control) SMV
The kinetics of GSH transport in SMV suspended
in the cryoprotective bu¡er was indistinguishable
from that in standard suspension bu¡ers (unpub-
lished observations). The initial rates of GSH uptake
under voltage-clamped and non-voltage-clamped
conditions were identical (not shown). The data rep-
resenting the kinetics of GSH transport in SMV are
shown in Fig. 2. Our modeling indicated that these
data were consistent with and could be ¢tted ad-
equately with the inclusion of only two saturable
kinetic components, with no requirement for inclu-
sion of a linear term representing passive di¡usion or
other non-speci¢c e¡ects. Our ¢ts resolved a high-
a⁄nity unit with Km = 0.13 þ 0.04 mM, characterized
by Michaelis^Menten kinetics, and a low-a⁄nity unit
with Km = 8.9 þ 0.6 mM, characterized by sigmoidal
kinetics (Hill coe⁄cient nV2). The ¢t to the kinetic
data, which yielded the parameter estimates indicated
above, is shown in Fig. 2. The high-a⁄nity range is
expanded in Fig. 2B to assist the visual inspection of
the data and the ¢t, as well as appreciation of the
relative contributions by the high- and low-a⁄nity
components. The Km values for both the high- and
Fig. 2. Kinetics of GSH transport in non-irradiated (control) SMV. Data represent the mean þ S.D., n = 4^7 preparations. Initial rates
of transport (10 s) were measured under voltage-clamped conditions from the uptake of [35S]GSH in the presence of GSH concentra-
tions ranging from trace (0.02 WM) to 50 mM. The continuous curve represents the overall ¢t to the total transport, obtained using
the sum of two components, a high-a⁄nity Michaelis^Menten unit and a low-a⁄nity sigmoidal (Hill coe⁄cient V2) unit. A passive
di¡usion component was not required. The broken and dotted curves show the ¢ts to the high- and low-a⁄nity units, respectively.
The right-hand panel shows the magni¢ed version of the high-a⁄nity region for visual appreciation of the ¢t and the relative contri-
butions of the two kinetic components to the total transport. Our kinetic analysis indicated that s 99.9% of transport at trace and
0.02 mM GSH is by the high-a⁄nity component, whereas s 95% of transport at 25 and 50 mM GSH is by the low-a⁄nity compo-
nent.
1 The size of 5P-nucleotidase estimated from inactivation of
this enzyme in CMV was erroneously reported as 83 þ 2 kDa in
our earlier study [22]. This value should have been 93 þ 2 kDa.
The correct value has subsequently been reported in a Corrigenda
in Am. J. Physiol. 275 (1998) U20.
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low-a⁄nity units estimated from our data were in the
range of those published heretofore using a variety of
experimental models [1,10^14]. However, there was a
major distinction, in that the kinetics of transport by
the low-a⁄nity unit in our SMV uncovered the sig-
moidicity that has consistently been observed in the
isolated^perfused liver and isolated hepatocyte mod-
els [1,6,7,10^12], but had been absent in the SMV
model [13,14]. Thus, our present observations of
the low-a⁄nity unit of GSH transport in SMV are
consistent with the other more physiological models.
Analysis of our kinetic data indicated that the high-
a⁄nity component has a low capacity for GSH, rel-
ative to the low-a⁄nity unit (Vmax ratio V5%).
However, at GSH levels below 0.2 mM, the high-
a⁄nity unit mediates s 99.9% of total transport
while it accounts for no more than V5% of total
transport at GSH levels above 25 mM. As before
[22], these properties enabled us to e¡ectively isolate
the high- and low-a⁄nity components to study their
characteristics by inactivation of transport at two
extremes of GSH concentration ranges, i.e., 0.02
WM (trace) and 0.02 mM vs. 25 mM and 50 mM
GSH (see below).
It may be noted that a high-a⁄nity component of
GSH transport, with characteristics similar to that in
SMV, has been reported in CMV [22,36,37]. Is it
possible that this high-a⁄nity component, observed
in our SMV, was due to the cross-contribution from
contaminating CMV? We estimated the impact of
this contribution by correcting for a maximal cross-
contamination (i.e., 10% of total SMV assumed to be
of CMV origin) as described in Section 2. Since spe-
ci¢c activities of GSH transport (nmol (mg
protein)31 10 s31) were very similar in SMV and
CMV, this correction had a negligible e¡ect on the
SMV data and estimates of kinetic parameters ob-
tained with and without correction for cross-contam-
ination were indistinguishable.
3.4. Radiation inactivation of sinusoidal GSH
transport
The high- and low-a⁄nity components of GSH
transport in SMV were studied by inactivation of
GSH transport at two extremes of the GSH concen-
tration range, i.e., at 0.02 WM (trace) and 0.02 mM
vs. 25 and 50 mM GSH, as stated above.
3.4.1. Inactivation of the high-a⁄nity unit
Post-irradiation transport of 0.02 WM and 0.02
mM GSH appeared to decay mono-exponentially
to plateau values equivalent to V7% and V15%
of their respective non-irradiated controls (Fig.
3A,B). Thus, a single exponential function without
the inclusion of a radiation-insensitive component
was not adequate to ¢t the data. The inclusion of a
radiation-insensitive component was mathematically
justi¢able from our inactivation data, and has been
used in target size analyses [33]. Nevertheless, we set
out to establish an experimental basis for inclusion of
such a component in our analysis by measuring the
Fig. 3. Inactivation of the high-a⁄nity transport of GSH. The
mean residual transports are shown in open circles at trace
GSH (A) in four independent preparations (n = 5) and at 0.02
mM GSH (B) in seven independent preparations (n = 7). Open
triangles represent the inhibited residual GSH transport in the
presence of 5 mM BSP-SG (mean of n = 2 independent SMV
preparations). The solid lines indicate the ¢ts obtained with a
mono-exponential function plus a constant equal to 5% for
trace and 15% for 0.02 mM GSH. Bars represent S.E. (see esti-
mated target sizes in text; Table 2).
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fraction of post-irradiation transport that was truly
non-inhibitable. Radiation-insensitive components
may be due to ‘non-speci¢c’ factors, such as binding
and/or passive di¡usion. Since BSP-SG is a compet-
itive inhibitor of sinusoidal GSH transport [10], we
determined the inactivation of the high-a⁄nity com-
ponent in the presence of 5 mM BSP-SG. In two
independent preparations, BSP-SG was found to in-
hibit an average of V95% and V85% of transport
at trace and 0.02 mM GSH, respectively, over the
range of all radiation doses (Fig. 3A,B, triangles).
Thus, V5% and V15% of unirradiated transport
at trace and 0.02 mM GSH, respectively, were found
to be uninhibitable, in all likelihood due to non-spe-
ci¢c binding or passive di¡usion of GSH.
On the basis of these ¢ndings, we analyzed resid-
ual transport data at 0.02 WM and 0.02 mM GSH
with a single exponential plus a constant, set at 5%
for 0.02 WM and 15% for 0.02 mM GSH. The ¢ts to
the data from each individual preparation resulted in
the estimated target sizes listed in Table 2. The esti-
mated mean functional sizes were 70.6 þ 4.9 kDa and
70.5 þ 6.8 kDa (mean þ S.E.) at 0.02 WM and 0.02
mM GSH, respectively. The ¢ts to the pooled data
sets are represented by the continuous lines in Fig.
3A,B. Conversely, we analyzed residual transport
data by subtracting the 5% and 15% non-inhibitable
fractions of transport, at 0.02 WM and 0.02 mM
GSH respectively, from the initial uptake rates. The
resulting functional sizes were similar to those listed
in Table 2.
3.4.2. Inactivation of the low-a⁄nity unit
Our attempts to study the inactivation of GSH
transport by the low-a⁄nity unit in SMV, by mea-
suring uptakes at 25 mM and 50 mM GSH, indi-
cated that GSH transport was neither inactivated in
the same manner nor to the same degree as in CMV
[22]. In contrast with the radiation e¡ects on GSH
transport in CMV, there was no marked initial acti-
vation at lower doses and the overall inactivation
was much less pronounced. Moreover, the smaller
e¡ects of radiation in SMV were accompanied by a
relatively greater scatter in the data. Fig. 4 presents
inactivation of transport for experiments conducted
with 25 mM GSH. Both individual experiments as
well as pooled data (inset) are shown. The data from
experiments conducted with 50 mM GSH (not
shown) exhibited similar characteristics, but even
higher scatter, and there was no overall improvement
when the data from both 25 and 50 mM GSH were
pooled.
Although the pooled data shown in the inset in
Fig. 4 could be ¢tted at face value using certain
assumptions, there are serious concerns that would
preclude treating the results from such analyses as
reliable and representative of the actual value of
the size of the transporter(s) involved. To begin
with, the relatively signi¢cant activity persisting at
the highest end of radiation doses (V40%) could
again be in large part due to ‘non-speci¢c’ factors,
such as binding of GSH to small unrelated protein(s)
or passive di¡usion, which would not decay with
irradiation. In case of the high-a⁄nity transport of
GSH in SMV, we were able to identify and correct
for such ‘non-speci¢c’ fractions by estimating the
fraction of transport that was not inhibitable by
BSP-SG. Unfortunately, it was not possible to iden-
tify and experimentally measure an analogous non-
inhibitable fraction in the low-a⁄nity transport of
GSH in SMV, since a potent and speci¢c, compet-
itive or non-competitive inhibitor that would accom-
plish this aim is not known. The use of BSP-SG, a
competitive inhibitor, is not feasible since the inhibi-
tion of uptake at 25 mM or 50 mM GSH would
require exceedingly and prohibitively high levels of
Table 2
Functional sizea (kDa) of sinusoidal high-a⁄nity GSH trans-
porter
Preparation no. Trace GSH;
NIF = 5%
0.02 mM GSH;
NIF = 15%
1 67.4 58.1
2 80.7 89.1
3 62.5 51.3
4 60.9 86.0
5 81.3 69.5
6 ^ 61.3
7 ^ 78.3
Mean þ S.E. 70.6 þ 4.9 70.5 þ 6.8
aFunctional sizes were estimated by ¢tting a mono-exponential
function plus a constant equal to NIF, the non-inhibitable frac-
tion ( = 5% at trace or 0.02 WM GSH and = 15% at 0.02 mM
GSH) to residual transport data in ¢ve (trace GSH) and seven
(0.02 mM GSH) independent preparations. NIF was estimated
by inhibition of the residual transport at trace and 0.02 mM
GSH by 5 mM BSP-SG (see Section 3).
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BSP-SG. Instead, we resorted to verify whether the
sizable residual transport of GSH at the highest end
of radiation doses would manifest trans-stimulation,
a benchmark of carrier-mediated transport. trans-
Stimulation of transport would rule out the possibil-
ity that all of the apparent radiation-insensitive re-
sidual activities were due to ‘non-speci¢c’ e¡ects. To
that end, we spot-checked the trans-stimulation of
the uptake of GSH by SMV, using duplicate deter-
minations in one preparation. Transport of GSH (2
mM) into SMV that were pre-loaded with 10 mM
GSH was trans-stimulated at all radiation doses (Fig.
5), indicating the presence of low-a⁄nity carrier-
mediated transport at higher radiation doses. Thus,
it appears that a signi¢cant but unquanti¢able mag-
nitude of transport by the low-a⁄nity unit remains
at higher radiation doses, representing carrier-medi-
ated transport rather than ‘non-speci¢c’ e¡ects.
Notwithstanding the caveats above, one could still
attempt to ¢t the pooled data presented in the inset
to Fig. 4 to gain as much insight into the range of
feasible sizes for the low-a⁄nity transporter as is
possible from our data. Such analysis (not shown)
resulted in a range of 12^25 kDa as the minimal
estimates of the low-a⁄nity component, obtained
with mono- and bi-exponential ¢ts without the inclu-
sion of any radiation-insensitive component. If a pu-
Fig. 5. trans-Stimulation of the uptake of 2 mM [35S]GSH in si-
nusoidal membrane vesicles pre-loaded with 10 mM GSH. The
bars represent the mean values of duplicate determinations in
one preparation. As in all other cases, transport was measured
under voltage-clamped conditions.
Fig. 4. Inactivation of the low-a⁄nity transport of GSH. Inactivation of the uptake of 25 mM GSH in SMV is shown for n = 6 indi-
vidual preparations, each shown by di¡erent symbols. The lack of marked decline by irradiation, combined with considerable scatter
in the data, precluded a meaningful analysis and the choice of an appropriate model to ¢t the data. The inset presents the means
(¢lled circles) and S.E. (bars) of the pooled data. Some ¢tting attempts to the pooled data set, based on various assumptions, are de-
scribed in text.
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tative radiation-insensitive fraction was included, it
tended to converge toV35% of unirradiated control,
yielding an estimate of 950 kDa for the low-a⁄nity
transporter. Potentially, this size represents the max-
imal estimate from our data since, in the above anal-
ysis, essentially all of the residual activities at the
highest doses were treated as ‘non-speci¢c’ e¡ects.
However, trans-stimulation of uptake counters this
view, indicating that the true size of the low-a⁄nity
unit is in all likelihood lower than 50 kDa. We em-
phasize that given the quantity and quality of our
data and the absence of any feasible methods (lack
of speci¢c inhibitor) to accurately assess the radia-
tion-insensitive component, it is not possible to de-
termine which of the above models is appropriate to
¢t the data to obtain reliable estimates. Nevertheless,
regardless of the choice of model, the target size of
the low-a⁄nity sinusoidal GSH transporter appears
to be smaller than the canalicular low-a⁄nity trans-
porter and the high-a⁄nity system of either domain.
4. Discussion
We have succeeded in preparing SMV fractions
that integrate all of the kinetic properties of GSH
transport observed with di¡erent experimental mod-
els in the past into a consistent, well-behaved model.
Our preparations exhibited both the high- and low-
a⁄nity components of GSH transport. However, the
signi¢cant new ¢nding was the manifestation of the
sigmoidicity in the kinetics of the low-a⁄nity com-
ponent of GSH transport in SMV, which had here-
tofore been missing in all past studies. This attribute
rendered our SMV preparations consistent with the
more physiological models, such as isolated perfused
livers and isolated hepatocytes. Moreover, the newly
determined kinetic characteristics and parameter val-
ues, indicated negligible cross-contributions to total
GSH transport by the two components at the ex-
tremes of low and high GSH concentrations, allow-
ing us to study properties of each, individually, by
target size analysis, using radiation inactivation.
The functional size of the high-a⁄nity sinusoidal
GSH transporter was resolved reliably and with pre-
cision from our inactivation data. However, unlike
the canalicular low-a⁄nity GSH transporter [22], si-
nusoidal low-a⁄nity transporter was found to be
much less sensitive to radiation, indicative of a con-
siderably smaller functional unit than the low-a⁄nity
canalicular transporter. Given the quantity and qual-
ity of the inactivation data, the functional size of the
low-a⁄nity sinusoidal GSH transporter could not be
estimated accurately, nor with precision. Therefore,
the identi¢cation of the structural basis for multiple
a⁄nities and apparent allosterism (sigmoidicity) in
the low-a⁄nity transport of sinusoidal GSH could
not be addressed meaningfully. The sigmoidal ki-
netics of the low-a⁄nity transport implies positive
cooperativity, either between multiple subunits in
an oligomeric carrier or between multiple sites on a
single polypeptide. Thus, the inability to reliably es-
timate the true size of the low-a⁄nity transporter
precludes any assessments as to whether the com-
plexity in the low-a⁄nity pathway is mediated by a
single polypeptide, or an oligomer, although a very
small target size does not seem plausible for an olig-
omer2.
Target-size analysis of the high-a⁄nity GSH trans-
port in SMV indicated that it is mediated by a single
protein structure, with a functional size ofV70 kDa,
which is similar to that of the high-a⁄nity compo-
nent for hepatic canalicular GSH transport we have
reported earlier [22]. The exact role of the high-a⁄n-
ity component of sinusoidal GSH transport is un-
2 The following are other possibilities, although less likely, that
could explain the modest inactivation of sinusoidal low-a⁄nity
transport. (a) We previously observed a substantial activation of
the low-a⁄nity transport of GSH in CMV at low doses (6 36
Mrad) of radiation [22]. Since V10% of the SMV used in our
study may be comprised of cross-contaminating canalicular frac-
tions, the radiation-induced activation of uptake in the contam-
inating CMV fractions could contribute to higher residual trans-
port in SMV. Again, correcting the residual transport in SMV for
contribution by cross-contaminating CMV did not have a signi¢-
cant impact on the inactivation data. (b) The sinusoidal low-af-
¢nity transport polypeptide may be less ‘sensitive’ to destruction
by a single electron hit, requiring multiple hits for equivalent
inactivation (higher radiation doses). The concept of multiple
hits was postulated as an exception to target theory [38,39], but
has not been experimentally established. These reports have pro-
posed the use of a theoretical ‘sensitivity’ factor in target analysis
to account for the putative di¡erential susceptibility of some pro-
teins to high-energy radiation-induced damage. Although such
proteins have never been identi¢ed, in principle, their inactivation
will require greater radiation exposures, relative to proteins of
similar size with higher ‘sensitivity’.
BBAMEM 77821 8-3-00
A.V. Mittur et al. / Biochimica et Biophysica Acta 1464 (2000) 207^218216
known, since it accounts for only a minor fraction of
the total transport (it has a much lower Vmax than
the low-a⁄nity component) and remains saturated
well below the physiological levels of cellular GSH.
It may be possible that the high-a⁄nity unit trans-
ports multiple substrates. Recent studies suggest that
oatp1, with unknown a⁄nity, may function as an
exchange transporter for GSH [21]. The molecular
size of oatp1 (V75 kDa) happens to be quite similar
to our estimate of the high-a⁄nity sinusoidal GSH
transporter. On the other hand, a number of physio-
logical features of sinusoidal GSH transport, which
have been observed at the low-a⁄nity ranges of GSH
transport, such as response to membrane potential
and thiol-disul¢des, e.g., cystine and DTT [6,7],
strongly indicate that oatp1 cannot be the major
and primary low-a⁄nity sinusoidal GSH transporter,
accounting for the bulk of physiological GSH e¥ux.
The functional size of the high-a⁄nity GSH carrier
in SMV is also similar to that of the high-a⁄nity
GSH carrier in CMV [22]. Taking into consideration
that the two proteins share common functions and
features in catalyzing the transport of GSH, it is
possible that the high-a⁄nity uptake of GSH in
SMV and CMV are mediated by the same protein
or by proteins that belong to the same family.
In conclusion, our studies clearly reveal that the
high- and low-a⁄nity components of hepatic sinus-
oidal transport of GSH are mediated by distinct car-
riers with dissimilar susceptibility to inactivation by
irradiation. The low-a⁄nity sinusoidal transporter of
GSH is smaller than the canalicular low-a⁄nity
transporter and the high-a⁄nity transporters of ei-
ther basolateral or apical plasma membrane do-
mains. The high-a⁄nity sinusoidal transporter of
GSH exhibits a functional size similar to both
oatp1 and the canalicular high-a⁄nity GSH trans-
porter.
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